Assay Detail
Binding
CHEMBL5336356
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of N-terminal full length GST-tagged SARS-CoV-2 3CLpro expressed in Escherichia coli BL21 (DE3) by using MCA-AVLQSGFR-Lys(Dnp)-Lys-NH as fluorogenic substrate preincubated with compound for 10 mins followed by substrate addition by FRET assay
5
Total Activities
5
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Target
Replicase polyprotein 1ab (CHEMBL4523582) ↗| Type | SINGLE PROTEIN |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
Publication
The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 5 | 5.80 | 6.41 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL8260 | BAICALEIN | 2.0 | 1 | 6.41 |
| CHEMBL5426064 | — | — | 1 | 5.92 |
| CHEMBL413552 | QUERCETAGETIN | — | 1 | 5.91 |
| CHEMBL164 | MYRICETIN | — | 1 | 5.54 |
| CHEMBL55415 | SCUTELLAREIN | — | 1 | 5.24 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL8260 | BAICALEIN | IC50 | = | 390.0 | nM | 6.41 |
| CHEMBL5426064 | — | IC50 | = | 1200.0 | nM | 5.92 |
| CHEMBL413552 | QUERCETAGETIN | IC50 | = | 1240.0 | nM | 5.91 |
| CHEMBL164 | MYRICETIN | IC50 | = | 2860.0 | nM | 5.54 |
| CHEMBL55415 | SCUTELLAREIN | IC50 | = | 5800.0 | nM | 5.24 |